Pharmacological inhibition of NLRP3-mediated pyroptosis can effectively alleviate podocyte injury in DN (Feng et al., 2021; Wang et al., 2022a; Zhang et al., 2022a). The gene discussed is NLRP3; the disease is liver dysplastic nodule.